CYCLANDELATE IN DIABETIC NEUROPATHY - A DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED, CROSS-OVER STUDY

被引：0

作者：

HEIMANS, JJ ^{[1
]}

DRUKARCH, B ^{[1
]}

MATTHAEI, I ^{[1
]}

IJFF, GA ^{[1
]}

BERTELSMANN, FW ^{[1
]}

STRIJERS, RLM ^{[1
]}

NAUTA, J ^{[1
]}

机构：

[1] FREE UNIV AMSTERDAM HOSP,DEPT THEORY MED,1007 MB AMSTERDAM,NETHERLANDS

来源：

ACTA NEUROLOGICA SCANDINAVICA | 1991年 / 84卷 / 06期

关键词：

DIABETIC NEUROPATHY; THERAPY; CYCLANDELATE;

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Cyclandelate has the ability to improve the rheological properties of the blood and therefore may improve blood supply of peripheral nerves. Previous studies in diabetic neuropathy have shown beneficial effects of the drug. We performed a double-blind, placebo-controlled, cross-over study in 40 diabetic patients with cyclandelate in a dose of 1600 mg daily. Motor and sensory nerve conduction velocities, late responses, thermal discrimination thresholds, vibration perception thresholds and pain scores were studied. We were not able to show any positive effect of the drug and therefore conclude that cyclandelate is not effective in the treatment of diabetic neuropathy.

引用

页码：483 / 486

页数：4

共 50 条

[21] TREATMENT OF OSTEOARTHRITIS WITH A HERBOMINERAL FORMULATION - A DOUBLE-BLIND, PLACEBO-CONTROLLED, CROSS-OVER STUDY
KULKARNI, RR
PATKI, PS
JOG, VP
GANDAGE, SG
PATWARDHAN, B
JOURNAL OF ETHNOPHARMACOLOGY, 1991, 33 (1-2) : 91 - 95
[22] Baclofen treatment for rumination syndrome: a double-blind, placebo-controlled, cross-over study
Pauwels, A.
Broers, C.
Van Houtte, B.
Rommel, N.
Vanuytsel, T.
Tack, J.
NEUROGASTROENTEROLOGY AND MOTILITY, 2016, 28 : 19 - 19
[23] A double-blind placebo-controlled study of the efficacy of cerenin on diabetic neuropathy
Thajeb, P
Lin, MS
Chen, PH
NEUROLOGY, 1996, 46 (02) : 1060 - 1060
[24] No effect of resveratrol supplementation in patients with mitochondrial myopathy - a randomized, double-blind, placebo-controlled, cross-over study
Lokken, N.
Khawajazada, T.
Storgaard, J.
Raaschou-Pedersen, D.
Orngreen, M.
Vissing, J.
NEUROMUSCULAR DISORDERS, 2019, 29 : S57 - S58
[25] Effect of AXOS on fecal water cytotoxicity and genotoxicity: a randomized, double-blind, placebo-controlled, cross-over study
Windey, Karen
De Preter, Vicky
Broekaert, Willem
Herman, Jean
Louat, Thierry
Verbeke, Kristin
FASEB JOURNAL, 2013, 27
[26] Effect of prasugrel in patients with asthma: results of PRINA, a randomized, double-blind, placebo-controlled, cross-over study
Lussana, F.
Di Marco, F.
Terraneo, S.
Parati, M.
Razzari, C.
Scavone, M.
Femia, E. A.
Moro, A.
Centanni, S.
Cattaneo, M.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 (01) : 136 - 141
[27] Circadian rhythms of hemostatic factors in tetraplegia: a double-blind, randomized, placebo-controlled cross-over study of melatonin
E Kostovski
A E A Dahm
M C Mowinckel
A Stranda
G Skretting
B Østerud
P M Sandset
P O Iversen
Spinal Cord, 2015, 53 : 285 - 290
[28] GH treatment in adults with chronic liver disease: A randomized, double-blind, placebo-controlled, cross-over study
Wallace, JD
Abbott-Johnson, WJ
Crawford, DHG
Barnard, R
Potter, JM
Cuneo, RC
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (06): : 2751 - 2759
[29] Circadian rhythms of hemostatic factors in tetraplegia: a double-blind, randomized, placebo-controlled cross-over study of melatonin
Kostovski, E.
Dahm, A. E. A.
Mowinckel, M. C.
Stranda, A.
Skretting, G.
Osterud, B.
Sandset, P. M.
Iversen, P. O.
SPINAL CORD, 2015, 53 (04) : 285 - 290
[30] Topical anticholinergic drugs in the treatment of multiple hidrocystomas: a cross-over, randomized, double-blind, placebo-controlled study
Sanz-Sanchez, T.
Perez-Alvarez, M. J.
Ortiz-del-Portillo, A.
Dauden, E.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2017, 31 (02) : E90 - E92

← 1 2 3 4 5 →